cariprazine
Selected indexed studies
- Cariprazine for Treating Schizophrenia, Mania, Bipolar Depression, and Unipolar Depression: A Review of Its Efficacy. (Cureus, 2023) [PMID:37378203]
- Cariprazine. (, 2012) [PMID:31643910]
- Cariprazine (Vraylar®). (, 1994) [PMID:39631014]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Cariprazine for Treating Schizophrenia, Mania, Bipolar Depression, and Unipolar Depression: A Review of Its Efficacy. (2023) pubmed
- Cariprazine. (2012) pubmed
- Cariprazine (Vraylar®). (1994) pubmed
- Cariprazine in Psychiatry: A Comprehensive Review of Efficacy, Safety, and Therapeutic Potential. (2024) pubmed
- Cariprazine in Bipolar Disorder and Substance Use: A Dual Approach to Treatment? (2024) pubmed
- Cariprazine-induced mania: A case series report. (2022) pubmed
- Cariprazine and Cognition in Patients with Schizophrenia and Bipolar Disorder: A Systematic Review. (2024) pubmed
- Cariprazine for treating psychosis: an updated meta-analysis. (2023) pubmed
- Cariprazine to Treat Schizophrenia and Bipolar Disorder in Adults. (2020) pubmed
- Adjunctive Cariprazine for the Treatment of Patients With Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study. (2023) pubmed